Stock Scorecard



Stock Summary for Iradimed Corp (IRMD) - $59.17 as of 1/21/2025 3:50:27 AM EST

Total Score

18 out of 30

Safety Score

47 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for IRMD

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for IRMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for IRMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for IRMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for IRMD (47 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 3
Price to Earnings (Max of 10) 2

Latest News for for IRMD

IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues 1/10/2025 1:30:00 PM
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference - iRadimed ( NASDAQ:IRMD ) 12/19/2024 1:30:00 PM
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference 12/19/2024 1:30:00 PM
IRADIMED CORPORATION on Forbes' List of America's Most Successful Small-Cap Companies for 2025 12/10/2024 1:30:00 PM
iRadimed Chief Financial Officer Sold $135K In Company Stock - iRadimed ( NASDAQ:IRMD ) 12/3/2024 3:01:00 PM
IRADIMED CORPORATION Named to Fortune's 100 Fastest Growing Companies List for 2024 11/4/2024 1:30:00 PM
IRadimed ( IRMD ) Beats Q3 Earnings and Revenue Estimates 10/31/2024 1:25:00 PM
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - iRadimed ( NASDAQ:IRMD ) 10/3/2024 8:05:00 PM
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference 10/3/2024 8:05:00 PM
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth "Big 8" Investor Conference - iRadimed ( NASDAQ:IRMD ) 9/10/2024 8:30:00 PM

Financial Details for IRMD

Company Overview

Ticker IRMD
Company Name Iradimed Corp
Country USA
Description IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. The company is headquartered in Winter Springs, Florida.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2024
Next Earnings Date 2/6/2025

Stock Price History

Last Day Price 59.17
Price 4 Years Ago 42.99
Last Day Price Updated 1/21/2025 3:50:27 AM EST
Last Day Volume 50,168
Average Daily Volume 44,802
52-Week High 59.31
52-Week Low 39.79
Last Price to 52 Week Low 48.71%

Valuation Measures

Trailing PE 40.53
Industry PE 54.15
Sector PE 41.24
5-Year Average PE 41.08
Free Cash Flow Ratio 14.50
Industry Free Cash Flow Ratio 34.23
Sector Free Cash Flow Ratio 27.18
Current Ratio Most Recent Quarter 9.21
Total Cash Per Share 4.08
Book Value Per Share Most Recent Quarter 6.58
Price to Book Ratio 8.99
Industry Price to Book Ratio 5.23
Sector Price to Book Ratio 20.52
Price to Sales Ratio Twelve Trailing Months 10.52
Industry Price to Sales Ratio Twelve Trailing Months 13.10
Sector Price to Sales Ratio Twelve Trailing Months 24.40
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 12,673,400
Market Capitalization 749,885,078
Institutional Ownership N/A

Dividends

Ex-Dividend Date 11/15/2024
Previous Dividend Amount 0.1500
Current Dividend Amount 0.1500
Total Years Dividend Increasing 2
Trailing Annual Dividend Rate 0.60
Trailing Annual Dividend Yield 1.02%
Forward Annual Dividend Rate 0.60
Forward Annual Dividend Yield 1.02%
5-Year Dividend Payments Count 7
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 200.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 200.00%
Dividend Payout Ratio 41.10%

Income Statement

Quarterly Earnings Growth YOY -0.40%
Annual Earnings Growth 34.02%
Reported EPS 12 Trailing Months 1.46
Reported EPS Past Year 1.21
Reported EPS Prior Year 1.48
Net Income Twelve Trailing Months 18,626,934
Net Income Past Year 17,192,776
Net Income Prior Year 12,828,487
Quarterly Revenue Growth YOY 11.00%
5-Year Revenue Growth 16.59%
Operating Margin Twelve Trailing Months 31.60%

Balance Sheet

Total Cash Most Recent Quarter 51,721,051
Total Cash Past Year 49,762,198
Total Cash Prior Year 57,960,864
Net Cash Position Most Recent Quarter 51,721,051
Net Cash Position Past Year 49,762,198
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 71,420,164
Total Stockholder Equity Prior Year 73,672,987
Total Stockholder Equity Most Recent Quarter 83,432,625

Free Cash Flow

Free Cash Flow Twelve Trailing Months 17,157,001
Free Cash Flow Per Share Twelve Trailing Months 1.35
Free Cash Flow Past Year 5,457,845
Free Cash Flow Prior Year 8,167,714

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 1.21
MACD Signal 0.89
20-Day Bollinger Lower Band 45.13
20-Day Bollinger Middle Band 52.14
20-Day Bollinger Upper Band 59.16
Beta 0.80
RSI 67.30
50-Day SMA 40.78
150-Day SMA 0.00
200-Day SMA 38.81

System

Modified 1/21/2025 3:50:28 AM EST